Aradigm Announces Receipt of Final FDA Minutes for the Type B Meetin...
02/21/19
Aradigm Announces Receipt of Final FDA Minutes for the Type B Meeting on January 25, 2019 Business Wire
Aradigm Corporation (Pink Market: ARDM) (“Aradigm” or the “Company”). At the Type B meeting, Aradigm presented the results of the Third Party Evaluati.
[more]